Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Takeda, Sanford-Burnham Ink Obesity Discovery Deal To Explore Non-CNS Options

This article was originally published in The Pink Sheet Daily

Executive Summary

Sanford-Burnham's Florida campus and Florida Hospital hope to speed discovery by comparing 'omics'-generated leads with data from human screening to eliminate missteps early.

You may also be interested in...



Financings Of The Fortnight: Post-JPM Glow And 2011's Uncertainties

Updates on Dendreon, Amarin, Rib-X and Civitas.

Financings Of The Fortnight: Post-JPM Glow And 2011's Uncertainties

Updates on Dendreon, Amarin, Rib-X and Civitas.

Pharma and Academia: Finding New Ways to Join Hands for Mutual Benefit

As Big Pharmas seek to hedge their development risk and look for more externally sourced programs, partnerships with academic institutions are one of the many ingredients in the R&D secret sauce. Such deals aren't the academic-industry tie-ups of yore-where Big Pharma sought small money partnerships without giving a lot back to their academic partners. Business development execs view them as yet another way to access critically important innovation.

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel